Prince Pharmaceutical Co., Ltd. (TPEX:6935)
Taiwan · Delayed Price · Currency is TWD 27.05
+1.10 (4.24%)
Jul 17, 2025, 1:35 PM CST
Prince Pharmaceutical Market Cap
Prince Pharmaceutical has a market cap or net worth of 949.90 million as of July 17, 2025. Its market cap has decreased by -4.24% in one year.
Market Cap
949.90M
Enterprise Value
1.31B
Revenue
690.03M
Ranking
n/a
PE Ratio
n/a
Stock Price
27.05
Market Cap Chart
Since March 29, 2023, Prince Pharmaceutical's market cap has decreased from 1.94B to 949.90M, a decrease of -51.13%. That is a compound annual growth rate of -26.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2025 | 990.17M | 23.52% |
| Dec 31, 2024 | 801.65M | -36.72% |
| Dec 29, 2023 | 1.27B | -34.82% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 188.45B |
| PharmaEssentia | 182.63B |
| Bora Pharmaceuticals Co., LTD. | 85.85B |
| Lotus Pharmaceutical | 56.80B |
| Oneness Biotech | 29.27B |
| Polaris Group | 28.81B |
| Center Laboratories | 26.28B |
| Lumosa Therapeutics | 24.48B |